Some of these proteins are quite recondite, in that there is no obvious enzymatic reason why a protein such as fumarylacetoacetase (fumarylacetoacetate hydrolase) should be enriched in stroke thrombi (its deficiency can be responsible for hereditary tyrosinemia type I [91–93]). This evidence concerns the gene FAH and stroke disorder.